<DOC>
	<DOCNO>NCT01475786</DOCNO>
	<brief_summary>The purpose study determine VM202 safe effective treat painful diabetic neuropathy .</brief_summary>
	<brief_title>Safety Efficacy Study Treatment Painful Diabetic Neuropathy</brief_title>
	<detailed_description>Peripheral neuropathy serious complication diabetes . This form neuropathy carry high risk pain , trophic change autonomic dysfunction . There currently effective treatment diabetic neuropathy , good glycemic control way minimize risk occurrence . Clearly , would desirable prevent , impede , reverse disrupt often life-threatening manifestation peripheral neuropathy stimulate growth regeneration peripheral nerve axon .</detailed_description>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Age ≥ 18 year ≤ 75 year Documented history Type I II diabetes current treatment control ( glycosylated hemoglobin A1c ≤ 10.0 % Screening ) currently oral medication and/or insulin Diagnosis painful diabetic peripheral neuropathy low extremity Lower extremity pain least 6 month Visual analog scale ( VAS ) score ≥ 40 mm Initial Screening ( 0 mm = pain 100 mm severe pain ) Symptoms Brief Pain Neuropathy Screening ( BPNS ) ≤ 5 point difference legs Initial Screening The average daily pain intensity score Daily Pain Sleep Interference Diary complete medication washout ≥ 4 standard deviation ≤ 2 The physical examination component Michigan Neuropathy Screening Instrument Score ( MNSI ) ≥ 3 Screening Stable treatment diabetes least 3 month anticipate change medication regimen , new symptom associate diabetes If female childbearing potential , negative urine pregnancy test screen use acceptable method birth control study Peripheral neuropathy cause condition diabetes Other pain severe neuropathic pain Progressive degenerative neurological disorder Myopathy Inflammatory disorder blood vessel ( inflammatory angiopathy , Buerger 's disease ) Active infection Chronic inflammatory disease ( e.g. , Crohn 's disease , rheumatoid arthritis ) Positive HIV HTLV Screening Active Hepatitis B C determine Hepatitis B core antibody ( HBcAB ) , antibody Hepatitis B antigen ( IgG IgM ; HbsAb ) , Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody ( AntiHCV ) Screening Subjects know immunosuppression currently receive immunosuppressive drug , chemotherapy radiation therapy Stroke myocardial infarction within last 3 month Ophthalmologic condition pertinent proliferative retinopathy condition preclude standard ophthalmologic examination Specific laboratory value Screening include : Hemoglobin &lt; 8.0 g/dL , WBC &lt; 3,000 cell per microliter , platelet count &lt; 75,000/mm3 , Creatinine &gt; 2.0 mg/dL ; AST and/or ALT &gt; 3 time upper limit normal clinically significant lab abnormality opinion investigator exclusionary Uncontrolled hypertension define sustain systolic blood pressure ( SBP ) &gt; 200 mmHg diastolic BP ( DBP ) &gt; 110 mmHg Screening Patients recent history ( &lt; 5 year ) new screen find malignant neoplasm except basal cell carcinoma squamous cell carcinoma skin ( excised evidence recurrence ) ; patient family history colon cancer first degree relative exclude unless undergone colonoscopy last 12 month negative finding Subjects require &gt; 81 mg daily acetylsalicylic acid ; If ≥ 81 mg take screening , subject may enrol willing/able switch another medication Use opioids ; subject may enrol willing able discontinue use drug 14 day prior start 7 Day Daily Pain Sleep Interference Diary refrain take drug duration study Subjects require regular COX2 inhibitor drug ( ) nonspecific COX1/COX2 inhibiting drug , high dose steroid ( except inhale steroid ) .Subjects may enrol willing/able undergo medication washout prior first dose refrain take drug duration study ; Major psychiatric disorder within last 6 month Body mass index ( BMI ) &gt; 45 kg/m2 Screening Any low extremity amputation Use investigational drug treatment past 6 month Unable unwilling give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>nerve pain</keyword>
	<keyword>diabetic nerve pain</keyword>
	<keyword>throb</keyword>
	<keyword>burning</keyword>
	<keyword>painful foot</keyword>
	<keyword>tingle</keyword>
	<keyword>numbness</keyword>
</DOC>